World

Menarini Group's ORSERDU® (Elacestrant) Study Advances in Metastatic Breast Cancer

ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...

 May 30, 2023 | News

Amplo Biotech Secures Fast Track Funding for Promising Gene Therapy Targeting Collagen Q Deficiency

Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...

 May 30, 2023 | News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo as neoadjuvant treatment for high-risk non-small cell lung cancer

If approved, Opdivo with chemotherapy would be the first and only neoadjuvant immunotherapy-based option authorized to treat patients with non-sm...

 May 29, 2023 | Regulatory

Novo Nordisk and Life Edit Therapeutics collaborate on gene editing therapies for rare and cardiometabolic diseases

Life Edit has the option to a global profit share on one programme. Novo Nordisk will make an equity investment in ElevateBio, Li...

 May 29, 2023 | News

Pfizer's PAXLOVID™ FDA-approved for high-risk adults with severe COVID-19

PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021 Approval is based on the total...

 May 29, 2023 | News

10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAs...

 May 25, 2023 | News

Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results

Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. GAAP net income of $302...

 May 24, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

 May 24, 2023 | News

Croda and Botanical Solution Inc. (BSI) Partner to Accelerate Sustainable Vaccine Adjuvant QS-21 Production

  “It provides opportunity to build a scalable, and truly sustainable supply chain of QS-21 to the pharmaceutical industry. The plentiful sup...

 May 23, 2023 | News

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix® Blood Test to Detect Prostate Cancer

Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced today that it entered into an agreement for Labcorp, a...

 May 22, 2023 | News

Abbott's Dual-Chamber Leadless Pacemaker Study Meets Primary Endpoints

Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber l...

 May 22, 2023 | News

Medtronic Extravascular ICD Trial Yields Positive Safety and Effectiveness Results

Late-breaking data at Heart Rhythm 2023 underscore performance of first-of-its-kind investigational defibrillator with the lead placed under the breas...

 May 22, 2023 | News

Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region

Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to del...

 May 19, 2023 | News

Discovery Life Sciences Joins Akoya Biosciences' Global Network to Boost Immuno-Oncology Research

With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...

 May 19, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close